A letter to healthcare professionals highlighting the extended use beyond labelled expiry date for selected lots of Jext 150 mcg and 300 mcg adrenaline auto-injectors has been updated.
The letter has information on specific lots (batch) numbers of Jext 150 mcg and Jext 300 mcg auto-injectors, which have their use extended beyond the labelled expiry date by four months.
Pharmacists are advised to be aware that Item 13 in the table of the original letter contained an incorrect batch number. The updated letter contains the correct batch details.
Further details of the letter, information on the extended use of the specified lots and recommendations to healthcare professionals, are available here.